featured
Correlations of Overall Response Rate and Progression-Free Survival With Overall Survival in Immunotherapy Trials for Metastatic NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis
Lancet Oncol 2024 Apr 01;25(4)455-462, BHL Goulart, SL Mushti, S Chatterjee, E Larkins, PS Mishra-Kalyani, R Pazdur, PG Kluetz, H SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.